Suppression of cardiac phosphatidate phosphohydrolase 1 activity and lipin mRNA expression in Zucker diabetic fatty rats and humans with type 2 diabetes mellitus

Biochemical and Biophysical Research Communications

Volumn 390, Issue 1, 2009, Pages 165-170

  Burgdorf, Christof ^a   Hänsel, Laura ^a   Heidbreder, Marc ^a   Jöhren, Olaf ^a   Schütte, Frank ^a   Schunkert, Heribert ^a   Kurz, Thomas ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Diabetes mellitus; Human atrial tissue; Lipin; Phosphatidate phosphohydrolase 1; Phospholipid biosynthesis; Zucker diabetic fatty rats

Indexed keywords

INSULIN; LIPIN 1; LIPIN 3; MESSENGER RNA; PHOSPHATIDATE PHOSPHATASE; PHOSPHATIDATE PHOSPHOHYDROLASE 1; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DIABETIC PATIENT; EX VIVO STUDY; EXPERIMENTAL ANIMAL; HEART LEFT VENTRICLE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; INSULIN TREATMENT; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN HEART SURGERY; PHOSPHOLIPID SYNTHESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ZUCKER DIABETIC FATTY RAT;

ANIMALS; DIABETES MELLITUS, TYPE 2; HEART ATRIA; HEART VENTRICLES; HUMANS; INSULIN; MALE; MYOCARDIUM; NUCLEAR PROTEINS; PHOSPHATIDATE PHOSPHATASE; RATS; RATS, ZUCKER; RNA, MESSENGER;

ANIMALIA; MAMMALIA; RATTUS;

EID: 70349947074     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.09.108     Document Type: Article

References (28)

1. Carman G.M., and Han G.S. Roles of phosphatidate phosphatase enzymes in lipid metabolism. Trends Biochem. Sci. 31 (2006) 694-699
2. Reue K., and Zhang P. The lipin protein family: dual roles in lipid biosynthesis and gene expression. FEBS Lett. 582 (2008) 90-96
3. Reue K., and Brindley D.N. Thematic review series: glycerolipids. Multiple roles for lipins/phosphatidate phosphatase enzymes in lipid metabolism. J. Lipid Res. 49 (2008) 2493-2503
4. Donkor J., Sariahmetoglu M., Dewald J., Brindley D.N., and Reue K. Three mammalian lipins act as phosphatidate phosphatases with distinct tissue expression patterns. J. Biol. Chem. 282 (2007) 3450-3457
5. Brindley D.N., and Waggoner D.W. Mammalian lipid phosphate phosphohydrolases. J. Biol. Chem. 273 (1998) 24281-24284
6. Brindley D.N., Pilquil C., Sariahmetoglu M., and Reue K. Phosphatidate degradation: phosphatidate phosphatases (lipins) and lipid phosphate phosphatases. Biochim. Biophys. Acta 1791 (2009) 956-961
7. Boudina S., and Abel E.D. Diabetic cardiomyopathy revisited. Circulation 115 (2007) 3213-3223
8. Murthy V.K., and Shipp J.C. Heart triglyceride synthesis in diabetes: selective increase in activity of enzymes of phosphatidate synthesis. J. Mol. Cell. Cardiol. 12 (1980) 299-309
9. Schoonderwoerd K., Broekhoven-Schokker S., Hulsmann W.C., and Stam H. Properties of phosphatidate phosphohydrolase and diacylglycerol acyltransferase activities in the isolated rat heart. Effect of glucagon, ischaemia and diabetes. Biochem. J. 268 (1990) 487-492
10. Williams S.A., Tappia P.S., Yu C.H., Bibeau M., and Panagia V. Impairment of the sarcolemmal phospholipase d-phosphatidate phosphohydrolase pathway in diabetic cardiomyopathy. J. Mol. Cell. Cardiol. 30 (1998) 109-118
11. Jamal Z., Martin A., Gomez-Muñoz A., Hales P., Chang E., Russell J.C., and Brindley D.N. Phosphatidate phosphohydrolases in liver, heart and adipose tissue of the JCR:LA corpulent rat and the lean genotypes: implications for glycerolipid synthesis and signal transduction. Int. J. Obes. Relat. Metab. Disord. 16 (1992) 789-799
12. Phan J., and Reue K. Lipin, a lipodystrophy and obesity gene. Cell Metab. 1 (2005) 73-83
13. Wiedmann S., Fischer M., Koehler M., Neureuther K., Riegger G., Doering A., Schunkert H., Hengstenberg C., and Baessler A. Genetic variants within the LPIN1 gene, encoding lipin, are influencing phenotypes of the metabolic syndrome in humans. Diabetes 57 (2008) 209-217
14. Aulchenko Y.S., Pullen J., Kloosterman W.P., Yazdanpanah M., Hofman A., Vaessen N., Snijders P.J., Zubakov D., Mackay I., Olavesen M., Sidhu B., Smith V.E., Carey A., Berezikov E., Uitterlinden A.G., Plasterk R.H., Oostra B.A., and van Duijn C.M. LPIN2 is associated with type 2 diabetes, glucose metabolism, and body composition. Diabetes 56 (2007) 3020-3026
15. 2-adrenoceptor-regulated norepinephrine overflow in failing hearts from Zucker diabetic fatty rats. J. Cardiovasc. Pharmacol. 47 (2006) 256-262
16. Lowry O.H., Rosebroug N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
17. Burgdorf C., Prey A., Richardt G., and Kurz T. A HPLC-fluorescence detection method for determination of phosphatidic acid phosphohydrolase activity: application in human myocardium. Anal. Biochem. 374 (2008) 291-297
18. Bligh E.G., and Dyer W.J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37 (1959) 911-917
19. Oltman C.L., Richou L.L., Davidson E.P., Coppey L.J., Lund D.D., and Yorek M.A. Progression of coronary and mesenteric vascular dysfunction in Zucker obese and Zucker diabetic fatty rats. Am. J. Physiol. Heart Circ. Physiol. 291 (2006) H1780-H1787
20. 2+-dependent phosphatidate phosphohydrolase, control of activity and subcellular distribution in vitro and in vivo. Biochem. J. 239 (1986) 275-284
21. Saggerson E.D., and Carpenter C.A. Effects of streptozotocin-diabetes and insulin administration in vivo or in vitro on the activities of five enzymes in the adipose-tissue triacylglycerol-synthesis pathway. Biochem. J. 243 (1987) 289-292
22. Farombi E.O., and Ige O.O. Hypolipidemic and antioxidant effects of ethanolic extract from dried calyx of Hibiscus sabdariffa in alloxan-induced diabetic rats. Fundam. Clin. Pharmacol. 21 (2007) 601-609
23. Whiting P.H., Bowley M., Sturton R.G., Pritchard P.H., Brindley D.N., and Hawthorne J.N. The effect of chronic diabetes, induced by streptozotocin, on the activities of some enzymes of glycerolipid synthesis in rat liver. Biochem. J. 168 (1977) 147-153
24. Croce M.A., Eagon J.C., LaRiviere L.L., Korenblat K.M., Klein S., and Finck B.N. Hepatic lipin 1beta expression is diminished in insulin-resistant obese subjects and is reactivated by marked weight loss. Diabetes 56 (2007) 2395-2399
25. Yao-Borengasser A., Rasouli N., Varma V., Miles L.M., Phanavanh B., Starks T.N., Phan J., Spencer III H.J., McGehee Jr. R.E., Reue K., and Kern P.A. Lipin expression is attenuated in adipose tissue of insulin-resistant human subjects and increases with peroxisome proliferator-activated receptor gamma activation. Diabetes 55 (2006) 2811-2818
26. Suviolahti E., Reue K., Cantor R.M., Phan J., Gentile M., Naukkarinen J., Soro-Paavonen A., Oksanen L., Kaprio J., Rissanen A., Salomaa V., Kontula K., Taskinen M.R., Pajukanta P., and Peltonen L. Cross-species analyses implicate lipin 1 involvement in human glucose metabolism. Hum. Mol. Genet. 15 (2006) 377-386
27. Harris T.E., Huffman T.A., Chi A., Shabanowitz J., Hunt D.F., Kumar A., and Lawrence Jr. J.C. Insulin controls subcellular localization and multisite phosphorylation of the phosphatidic acid phosphatase, lipin-1. J. Biol. Chem. 282 (2007) 277-286
28. Manmontri B., Sariahmetoglu M., Donkor J., Bou Khalil M., Sundaram M., Yao Z., Reue K., Lehner R., and Brindley D.N. Glucocorticoids and cyclic AMP selectively increase hepatic lipin-1 expression, and insulin acts antagonistically. J. Lipid Res. 49 (2008) 1056-1067